Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty — Stella

Home/Mild to Moderate Corneal Endothelial Decompensation/

View on ClinicalTrials.gov

Recruiting

Back to Mild to Moderate Corneal Endothelial Decompensation trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Singapore

Singapore Eye Research Institute, Singapore

Key details

Phase

Early testing

Sponsor

Singapore Eye Research Institute

Enrollment target

~30 participants

Started

December 2017

Primary completion

December 2027

Age range

21 Years – 80 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.